PMID- 27331589 OWN - NLM STAT- MEDLINE DCOM- 20170523 LR - 20200930 IS - 1944-7884 (Electronic) IS - 1525-4135 (Print) IS - 1525-4135 (Linking) VI - 72 Suppl 1 IP - Suppl 1 DP - 2016 Jun 1 TI - Safety and Efficacy of the PrePex Male Circumcision Device: Results From Pilot Implementation Studies in Mozambique, South Africa, and Zambia. PG - S43-8 LID - 10.1097/QAI.0000000000000742 [doi] AB - BACKGROUND: Fourteen countries in East and Southern Africa have engaged in national programs to accelerate the provision of voluntary medical male circumcision (VMMC) since 2007. Devices have the potential to accelerate VMMC programs by making the procedure easier, quicker, more efficient, and widely accessible. METHODS: Pilot Implementation studies were conducted in Mozambique, South Africa, and Zambia. The primary objective of the studies was to assess the safety of PrePex device procedures when conducted by nurses and clinical officers in adults and adolescent males (13-17 years, South Africa only) with the following end points: number and grade of adverse events (AEs); pain-related AEs measured using visual analog score; device displacements/self-removals; time to complete wound healing; and procedure times for device placement and removal. RESULTS: A total of 1401 participants (1318 adult and 83 adolescent males) were circumcised using the PrePex device across the 3 studies. Rates of moderate/severe AEs were low (1.0%; 2.0%; and 2.8%) in the studies in Mozambique, Zambia, and South Africa, respectively. Eight early self-removals of 1401 (0.6%) were observed, all required corrective surgery. High rates of moderate/severe pain-related AEs were recorded especially at device removal in South Africa (34.9%) and Mozambique (59.5%). Ninety percent of participants were healed at day 56 postplacement. DISCUSSION: The study results from the 3 countries suggest that the implementation of the PrePex device using nonphysician health care workers is both safe and feasible, but better pain control at device removal needs to be put in place to increase the comfort of VMMC clients using the PrePex device. FAU - Feldblum, Paul AU - Feldblum P AD - *Global Health Department, FHI 360, Durham, NC; daggerPeri-natal HIV Research Unit, Faculty of Health Sciences, University of Witswatersrand, Johannesburg, South Africa; section signUniversity Teaching Hospital, Lusaka, Zambia; ||Population Services International, Washington, DC; paragraph signJhpiego, Maputo Mocambique; #Society for Family Health, Lusaka, Zambia; **Population Services International Lusaka, Zambia; double daggerdouble daggerSociety for Family Health, Johannesburg, South Africa; section sign section signJhpiego, Baltimore, MD; || ||Population Services International, Maputo, Mozambique; paragraph sign paragraph signFHI 360, Nairobi, Kenya; and ##Population Services International, Harare, Zimbabwe. FAU - Martinson, Neil AU - Martinson N FAU - Bvulani, Bruce AU - Bvulani B FAU - Taruberekera, Noah AU - Taruberekera N FAU - Mahomed, Mehebub AU - Mahomed M FAU - Chintu, Namwinga AU - Chintu N FAU - Milovanovic, Minja AU - Milovanovic M FAU - Hart, Catherine AU - Hart C FAU - Billy, Scott AU - Billy S FAU - Necochea, Edgar AU - Necochea E FAU - Samona, Alick AU - Samona A FAU - Mhazo, Miriam AU - Mhazo M FAU - Bossemeyer, Debora AU - Bossemeyer D FAU - Lai, Jaim Jou AU - Lai JJ FAU - Lebinai, Limakatso AU - Lebinai L FAU - Ashengo, Tigistu A AU - Ashengo TA FAU - Macaringue, Lucinda AU - Macaringue L FAU - Veena, Valentine AU - Veena V FAU - Hatzold, Karin AU - Hatzold K LA - eng GR - U2G PS001542/PS/NCHHSTP CDC HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Acquir Immune Defic Syndr JT - Journal of acquired immune deficiency syndromes (1999) JID - 100892005 SB - IM MH - Adolescent MH - Adult MH - Circumcision, Male/adverse effects/*instrumentation MH - Humans MH - Male MH - Middle Aged MH - Mozambique MH - Pain Measurement MH - Prospective Studies MH - South Africa MH - Wound Healing MH - Young Adult MH - Zambia PMC - PMC4936427 COIS- The authors have no conflicts of interest to disclose. EDAT- 2016/06/23 06:00 MHDA- 2017/05/24 06:00 PMCR- 2016/07/07 CRDT- 2016/06/23 06:00 PHST- 2016/06/23 06:00 [entrez] PHST- 2016/06/23 06:00 [pubmed] PHST- 2017/05/24 06:00 [medline] PHST- 2016/07/07 00:00 [pmc-release] AID - 00126334-201606011-00008 [pii] AID - QAIV15822 [pii] AID - 10.1097/QAI.0000000000000742 [doi] PST - ppublish SO - J Acquir Immune Defic Syndr. 2016 Jun 1;72 Suppl 1(Suppl 1):S43-8. doi: 10.1097/QAI.0000000000000742.